To enhance blood serum 25(OH)D level in patients with vitamin D deficiencies (25(OH)D <30 ng/mL).
Adults and children 12 years old and above: 1 chewable tablet once daily. May be taken with or without food.
Hypersensitivity. Hypercalcemia and/or hypercalciuria. Calcium nephrolithiasis, nephrocalcinosis, hypervitaminosis D. Severe kidney damage and kidney failure.
Patients with impaired kidney function. Risk of soft tissue calcification should be account. Severe kidney insufficiencies. Patients with a tendency of kidney stone which contains calcium. Patients receiving cardiovascular medication, ie. cardiac glycosides. Sarcoidosis. The use of vitamin D preparations in the treatment of hyperparathyroidism associated with cardiovascular disease is not recommended, as it may lead to kidney failure. Pregnancy, lactation.
Discontinue use if severe allergy symptoms occur, including: swelling of the face, lips, tongue, and throat, difficulty swallowing, itching, and difficulty breathing.
Uncommon (<1/100): hypercalciuria and hypercalcemia.
Rarely (<1/1000): pruritus, rash, urticaria.
Concomitant use with cardiac glycosides, benzothiadiazine derivatives, thiazide, vitamin D analogue or metabolite, anticonvulsants (phenytoin, phenobarb, primidone), rifampicin, isoniazid, orlistat, liquid paraffin, cholestyramine, cytotoxic agent, actinomycin, antifungal imidazole, glucocorticoid, multivitamins and minerals, aluminum hydroxides, magnesium salts, sucralfate, calcium salts, conivaptan, aripiprazole, axitinib, saxagliptin, bile acid sequestrant, systemic corticosteroid, CYP3A4 inducers, deferasirox, mineral oils, orlistat, sevelamer, tocilizumab, hydantoin, barbiturates.
A11CC05 - colecalciferol ; Belongs to the class of vitamin D and analogues. Used as dietary supplements.
Cholecalciferol 5000 Imedco Djaja chewable tab 5,000 IU
5 × 6's
Sign Out
Lanjutkan dengan Google
Daftar dengan Email
Sudah menjadi anggota?
Masuk
